sur Applied DNA Sciences (NASDAQ:APDN )
Applied DNA to Participate in Maxim Healthcare Virtual Summit 2024
Applied DNA Sciences, Inc., a leader in PCR-based DNA technologies, has announced its participation in the 2024 Maxim Healthcare Virtual Summit. Dr. James A. Hayward, the company's president and CEO, will engage in a fireside chat during the summit, which is organized by Maxim Group LLC and runs from October 15th to 17th.
Dr. Hayward's discussion will be conducted by Dr. Jason McCarthy, Maxim's senior managing director and head of Biotechnology Research. The session will be accessible to registered attendees on October 16, 2024, at 12:50 p.m. EDT.
Applied DNA is known for its advancements in DNA and RNA technologies, serving markets in synthetic DNA production, molecular diagnostics, and industrial supply chain security.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Applied DNA Sciences